Table 1.
Pre-treatment patient characteristics (n = 1947)
| Criteria | Cervical cancer (n = 1668) | Endometrial cancer (n = 279) |
|---|---|---|
| Age | ||
| Range | 32-69 years | 45-74 years |
| Median | 41 years | 58 years |
| Operative status | ||
| Postoperative | 200 (12%) | 220 (79%) |
| Inoperable | 1468 (88%) | 59 (21%) |
| Stage (FIGO) | ||
| I | 71 (4%) | 114 (41%) |
| II | 468 (28%) | 106 (38%) |
| III | 1033 (62%) | 45 (16%) |
| IV | 96 (6%) | 14 (5%) |
| Karnofsky performance status | ||
| ≥ 90 | 1108 (66%) | 154 (55%) |
| 80-90 | 341 (20%) | 92 (33%) |
| 70-80 | 197 (12%) | 24 (9%) |
| 60-70 | 22 (1%) | 9 (3%) |
| Hemoglobin | ||
| > 10 gm% | 1301 (78%) | 248 (89%) |
| < 10 gm% | 367 (22%) | 31 (11%) |
| Serum creatinine | ||
| ≤ 1.5 times of normal | 1384 (83%) | 251 (90%) |
| ≥ 1.5 times of normal | 284 (17%) | 28 (10%) |
| Echocardiogram | ||
| Within normal limits | 1535 (92%) | 234 (84%) |
| Outside normal limits | 133 (8%) | 45 (16%) |
| Postprandial blood sugar | ||
| Within normal limits | 1568 (94%) | 215 (77%) |
| Outside normal limits | 100 (6%) | 64 (23%) |